Literature DB >> 29911821

At-a-glance - Impact of drug overdose-related deaths on life expectancy at birth in British Columbia.

Xibiao Ye1, Jenny Sutherland1, Bonnie Henry1, Mark Tyndall2, Perry Robert William Kendall1.   

Abstract

We quantified the contributions of leading causes of death and drug overdose to changes in life expectancy at birth over time and inequalities by sex and socioeconomic status in British Columbia. From 2014 to 2016, life expectancy at birth declined by 0.38 years and drug overdose deaths (mainly opioid-involved) contributed a loss of 0.12 years of the decrease. The analysis also demonstrated that the higher drug overdose mortality among males and among those in lower socioeconomic status communities contributed to a differential decrease in life expectancy at birth for males and for those in the latter category.

Entities:  

Keywords:  inequality; life expectancy at birth; opioid overdose death

Mesh：

Year:  2018        PMID： 29911821      PMCID： PMC6034969          DOI： 10.24095/hpcdp.38.6.05

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN： 2368-738X            Impact factor:   3.240


  7 in total

Review 1.  An area-based material and social deprivation index for public health in Québec and Canada.

Authors:  Robert Pampalon; Denis Hamel; Philippe Gamache; Mathieu D Philibert; Guy Raymond; André Simpson
Journal:  Can J Public Health       Date:  2012-04-30

2.  Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015.

Authors:  Deborah Dowell; Elizabeth Arias; Kenneth Kochanek; Robert Anderson; Gery P Guy; Jan L Losby; Grant Baldwin
Journal:  JAMA       Date:  2017-09-19       Impact factor: 56.272

3.  Drug-related deaths: Statistics based on death certificates miss one-third of cases.

Authors:  Anna Fugelstad; Mats Ramstedt; Ingemar Thiblin; Lars Age Johansson
Journal:  Scand J Public Health       Date:  2017-12-05       Impact factor: 3.021

4.  Measuring and explaining the change in life expectancies.

Authors:  E E Arriaga
Journal:  Demography       Date:  1984-02

5.  Variation in life expectancy and mortality by cause among neighbourhoods in King County, WA, USA, 1990-2014: a census tract-level analysis for the Global Burden of Disease Study 2015.

Authors:  Laura Dwyer-Lindgren; Rebecca W Stubbs; Amelia Bertozzi-Villa; Chloe Morozoff; Charlton Callender; Samuel B Finegold; Shreya Shirude; Abraham D Flaxman; Amy Laurent; Eli Kern; Jeffrey S Duchin; David Fleming; Ali H Mokdad; Christopher J L Murray
Journal:  Lancet Public Health       Date:  2017-09-05

6.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

7.  Life expectancy ranking of Canadians among the populations in selected OECD countries and its disparities among British Columbians.

Authors:  Li Rita Zhang; Drona Rasali
Journal:  Arch Public Health       Date:  2015-04-03
  7 in total
  18 in total

1.  Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.

Authors:  Michael A Irvine; Margot Kuo; Jane A Buxton; Robert Balshaw; Michael Otterstatter; Laura Macdougall; M-J Milloy; Aamir Bharmal; Bonnie Henry; Mark Tyndall; Daniel Coombs; Mark Gilbert
Journal:  Addiction       Date:  2019-06-28       Impact factor: 6.526

2.  Commentary - Building the evidence base for sustained public health response to the opioid epidemic in Canada.

Authors:  Theresa Tam
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

3.  Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.

Authors:  Benedikt Fischer; Michelle Pang; Mark Tyndall
Journal:  J Public Health (Oxf)       Date:  2020-11-23       Impact factor: 2.341

4.  Stepping up to the Canadian opioid crisis: a longitudinal analysis of the correlation between socioeconomic status and population rates of opioid-related mortality, hospitalization and emergency department visits (2000-2017).

Authors:  Mhd Wasem Alsabbagh; Martin Cooke; Susan J Elliott; Feng Chang; Noor-Ul-Huda Shah; Marco Ghobrial
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-06       Impact factor: 2.725

5.  At-a-glance - The impact of poisoning-related mortality on life expectancy at birth in Canada, 2000 to 2016.

Authors:  Heather M Orpana; Justin J Lang; Diana George; Jessica Halverson
Journal:  Health Promot Chronic Dis Prev Can       Date:  2019-02       Impact factor: 3.240

6.  The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study.

Authors:  Sierra Williams; Tanis King; Kristi Papamihali; Jane A Buxton
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

7.  Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.

Authors:  Kanna Hayashi; Evan Wood; Huiru Dong; Jane A Buxton; Nadia Fairbairn; Kora DeBeck; M-J Milloy; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2021-02-18

8.  "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis.

Authors:  Trevor Goodyear; Caroline Mniszak; Emily Jenkins; Danya Fast; Rod Knight
Journal:  Harm Reduct J       Date:  2020-03-30

9.  Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.

Authors:  Lindsay A Pearce; Jeong Eun Min; Micah Piske; Haoxuan Zhou; Fahmida Homayra; Amanda Slaunwhite; Mike Irvine; Gina McGowan; Bohdan Nosyk
Journal:  BMJ       Date:  2020-03-31

10.  Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.

Authors:  N Maghsoudi; K McDonald; C Stefan; D R Beriault; K Mason; L Barnaby; J Altenberg; R D MacDonald; J Caldwell; R Nisenbaum; P Leece; T M Watson; K W Tupper; L Kufner; A I Scheim; D Werb
Journal:  Harm Reduct J       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.